Fibroblast growth factor-2-overexpressing myoblasts encapsulated in alginate spheres increase proliferation, reduce apoptosis, induce adipogenesis, and enhance regeneration following skeletal muscle injury in rats.

The fibroblast growth factor 2 (FGF-2) is known as pleiotropic cytokine with myoblast proliferative properties. In the present study, we tested the hypothesis that gene transfer of human FGF-2 via transplantation of genetically modified L8-myoblast encapsulated in alginate modulates the skeletal muscle recovery after crush injury in Wistar rats. Therefore, we performed a crush injury to the soleus muscle and transplanted alginate spheres containing myoblasts genetically modified to overexpress human FGF-2 (FGF-2) or a luciferase (LUC) cDNA at the site of injury. Animals that underwent muscle injury without transplantation of alginate spheres served as control (control). At day 4 after trauma the FGF-2 group showed significant higher mean values of cell proliferation (bromodeoxyuridine immunohistochemistry) and significant lower values of cell apoptosis (terminal deoxynucleotidyl transferase nick end labeling histology) compared to animals receiving luciferase-overexpressing myoblasts. At the same time point adiponectin expression (ACRP30 immunohistochemistry) was increased in the FGF-2 group exclusively. The p75(NTR) expression (p75(NTR) immunohistochemistry) significantly improved in both the FGF-2 and LUC group compared to the control group. Functional analysis of the injured muscle did not reveal a significant increase of the muscle force in the FGF-2 group compared to the control and LUC group 14 days after injury. In vitro analysis for 14 days of the FGF-2-modified spheres demonstrated at day 7 and day 14 a significant increase of the relative cell count as well as of the relative viable cell count in the FGF-2 myoblast spheres compared to luciferase myoblast spheres. Additionally, the expression of FGF-2 (enzyme-linked immunosorbent assay analysis) and luciferase (chemiluminescence analysis) persisted in vitro for 4 and 14 days, respectively. These results demonstrate that FGF-2-overexpressing myoblasts cannot considerably improve muscle strength but are able to modulate the proliferation as well as the apoptosis of injured muscle tissue mainly by conducting adipogenesis.

[1]  T. Best,et al.  The role of neutrophils in injury and repair following muscle stretch , 2006, Journal of anatomy.

[2]  T. Partridge,et al.  Muscle satellite cells. , 2003, The international journal of biochemistry & cell biology.

[3]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[4]  K Remberger,et al.  Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I) , 2005, Gene Therapy.

[5]  D. Zurakowski,et al.  Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF‐2) in vivo , 2006, The journal of gene medicine.

[6]  L. Chandler,et al.  Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Y. Kato,et al.  Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. , 2001, Biochemical and biophysical research communications.

[8]  R. Seger,et al.  Fibroblast Growth Factor Promotes Recruitment of Skeletal Muscle Satellite Cells in Young and Old Rats , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  B. Riley,et al.  Role of FGFs in skeletal muscle and limb development , 1994, Molecular reproduction and development.

[10]  A. Giatromanolaki,et al.  Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis , 2005, British Journal of Sports Medicine.

[11]  M. Fujita,et al.  Basic fibroblast growth factor protects cardiac myocytes from iNOS‐mediated apoptosis , 2002, Journal of cellular physiology.

[12]  A. Kozubík,et al.  High molecular weight FGF2: the biology of a nuclear growth factor , 2008, Cellular and Molecular Life Sciences.

[13]  In-Kyu Park,et al.  Nonviral Approaches for Neuronal Delivery of Nucleic Acids , 2007, Pharmaceutical Research.

[14]  L. Jacobsen,et al.  FuGENE 6 Transfection Reagent: the gentle power. , 2004, Methods.

[15]  N. Ozaki,et al.  Fibroblast growth factor‐2 enhances functional recovery of reinnervated muscle , 2006, Muscle & nerve.

[16]  Q. Lu,et al.  Non-viral gene delivery in skeletal muscle: a protein factory , 2003, Gene Therapy.

[17]  T. Mittlmeier,et al.  Open blunt crush injury of different severity determines nature and extent of local tissue regeneration and repair , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  E. Brandan,et al.  Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration , 2004, Journal of cellular physiology.

[19]  J. Pedraz,et al.  Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. , 2006, Biomaterials.

[20]  David J Mooney,et al.  Alginate hydrogels as biomaterials. , 2006, Macromolecular bioscience.

[21]  T. Mittlmeier,et al.  Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  A. Arnold,et al.  Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and ExGen 500 , 2006, Fundamental & clinical pharmacology.

[23]  C. Meisinger,et al.  Regulation of nerve growth factor and its low‐affinity receptor (p75NTR) during myogenic differentiation , 1998, Journal of cellular physiology.

[24]  R. Bruno,et al.  Regulation of the p75 Neurotrophin Receptor in a Rat Myogenic Cell Line (L6) , 1999, The Histochemical Journal.

[25]  A. Mikos,et al.  Gene delivery strategies for cartilage tissue engineering. , 2006, Advanced drug delivery reviews.

[26]  L. J. Lee,et al.  The prolonged survival of fibroblasts with forced lipid catabolism in visceral fat following encapsulation in alginate-poly-L-lysine. , 2012, Biomaterials.

[27]  D. Zurakowski,et al.  Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation , 2004, The journal of gene medicine.

[28]  David J Mooney,et al.  The tensile properties of alginate hydrogels. , 2004, Biomaterials.

[29]  Smadar Cohen,et al.  Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. , 2006, Tissue engineering.

[30]  M. Menger,et al.  Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid‐mediated gene transfer in a gel suspension delivery system , 2003, The journal of gene medicine.

[31]  Heiko Zimmermann,et al.  Alginate-based encapsulation of cells: Past, present, and future , 2007, Current diabetes reports.

[32]  F. Booth,et al.  Fibroblast growth factor 2‐stimulated proliferation is lower in muscle precursor cells from old rats , 2009, Experimental physiology.

[33]  K. Schaser,et al.  Initial intramuscular perfusion pressure predicts early skeletal muscle function following isolated tibial fractures , 2008, Journal of orthopaedic surgery and research.

[34]  M. Järvinen,et al.  Muscle injuries: optimising recovery. , 2007, Best practice & research. Clinical rheumatology.

[35]  G. Pari,et al.  Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. , 1999, Human gene therapy.

[36]  D. Curiel,et al.  Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. , 1999, Cancer research.

[37]  T. Lamb,et al.  Inverted photocurrent responses from amphibian rod photoreceptors: role of membrane voltage in response recovery , 2005, The Journal of physiology.

[38]  A. Wagatsuma.  Adipogenic potential can be activated during muscle regeneration , 2007, Molecular and Cellular Biochemistry.

[39]  Michael A. Rudnicki,et al.  Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis , 2010, Nature Cell Biology.

[40]  J. W. Von den Hoff,et al.  Regulatory factors and cell populations involved in skeletal muscle regeneration , 2010, Journal of cellular physiology.

[41]  D. Kohn,et al.  Analysis of Novel Nonviral Gene Transfer Systems for Gene Delivery to Cells of the Musculoskeletal System , 2008, Molecular biotechnology.

[42]  P. Chang,et al.  Enhancement of myoblast microencapsulation for gene therapy. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[43]  D. Curiel,et al.  Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. , 1997, Cancer research.

[44]  Thomas C Chen,et al.  Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. , 2005, Journal of neurosurgery.

[45]  D. Lacey,et al.  Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Taro Matsumoto,et al.  p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2–stimulated angiogenesis , 2002, The Journal of cell biology.

[47]  D. Zurakowski,et al.  Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo , 2010, Archives of Orthopaedic and Trauma Surgery.

[48]  K. Christman,et al.  Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices , 2012, Biomedical Microdevices.

[49]  C. Erck,et al.  Evidence for the participation of nerve growth factor and its low‐affinity receptor (p75NTR) in the regulation of the myogenic program , 1998, Journal of cellular physiology.

[50]  E. Wahlberg,et al.  Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia. , 2004, Journal of vascular surgery.

[51]  K. Messmer,et al.  Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". , 1992, The American journal of physiology.

[52]  J. Cannon,et al.  Cytokines in exertion-induced skeletal muscle injury , 1998, Molecular and Cellular Biochemistry.

[53]  M. Simons.  Integrative signaling in angiogenesis , 2004, Molecular and Cellular Biochemistry.

[54]  N. Kotov,et al.  Three-dimensional cell culture matrices: state of the art. , 2008, Tissue engineering. Part B, Reviews.

[55]  A. Ascensão,et al.  Skeletal muscle atrophy increases cell proliferation in mice gastrocnemius during the first week of hindlimb suspension , 2006, European Journal of Applied Physiology.

[56]  A. Issekutz,et al.  Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. , 2006, The American journal of pathology.

[57]  T. Mittlmeier,et al.  Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. , 2007, Journal of applied physiology.

[58]  M. Yacoub,et al.  Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts. , 1998, The Journal of thoracic and cardiovascular surgery.

[59]  S. Braun,et al.  Muscular gene transfer using nonviral vectors. , 2008, Current gene therapy.

[60]  M. Boninger,et al.  The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. , 2009, American journal of physical medicine & rehabilitation.